Compared female and male patients’ exposure scores from DELCQ in SSc and RA
| Exposure scores . | SSc (n = 100) . | RA (n = 97) . | |||||
|---|---|---|---|---|---|---|---|
| Women (n = 74) . | Men (n = 26) . | P* . | Women (n = 77) . | Men (n = 20) . | P* . | ||
| GES | Mean | 20.7 (s.d. = 14.5) | 46.5 (s.d. = 19.7) | 1.27*10-7 | 25.3 (s.d. = 15.0) | 40.1(s.d. = 20.7) | 0.002 |
| Median | 17.5 (IQR = 20.0) | 47.0 (IQR = 23.0) | 25.0 (IQR = 21.0) | 42.5 (IQR = 28.0) | |||
| OES | Mean | 8.0 (s.d. = 8.5) | 30.0 (s.d. = 18.3) | 3.37*10-9 | 9.6 (s.d. = 9.0) | 26.5 (s.d. = 16.2) | 4.11*10-6 |
| Median | 6.0 (IQR = 13.0) | 26.0 (IQR = 22.0) | 7.0 (IQR = 11.0) | 23.5 (IQR = 16.5) | |||
| NOES | Mean | 12.7 (s.d. = 9.7) | 16.4 (s.d. = 9.5) | 0.08 | 15.7 (s.d. = 8.9) | 13.5 (s.d. = 9.9) | 0.31 |
| Median | 11 (IQR = 14.0) | 15.5 (IQR = 17.0) | 15.0 (IQR = 12.0) | 12.0 (IQR = 15.5) | |||
| Exposure scores . | SSc (n = 100) . | RA (n = 97) . | |||||
|---|---|---|---|---|---|---|---|
| Women (n = 74) . | Men (n = 26) . | P* . | Women (n = 77) . | Men (n = 20) . | P* . | ||
| GES | Mean | 20.7 (s.d. = 14.5) | 46.5 (s.d. = 19.7) | 1.27*10-7 | 25.3 (s.d. = 15.0) | 40.1(s.d. = 20.7) | 0.002 |
| Median | 17.5 (IQR = 20.0) | 47.0 (IQR = 23.0) | 25.0 (IQR = 21.0) | 42.5 (IQR = 28.0) | |||
| OES | Mean | 8.0 (s.d. = 8.5) | 30.0 (s.d. = 18.3) | 3.37*10-9 | 9.6 (s.d. = 9.0) | 26.5 (s.d. = 16.2) | 4.11*10-6 |
| Median | 6.0 (IQR = 13.0) | 26.0 (IQR = 22.0) | 7.0 (IQR = 11.0) | 23.5 (IQR = 16.5) | |||
| NOES | Mean | 12.7 (s.d. = 9.7) | 16.4 (s.d. = 9.5) | 0.08 | 15.7 (s.d. = 8.9) | 13.5 (s.d. = 9.9) | 0.31 |
| Median | 11 (IQR = 14.0) | 15.5 (IQR = 17.0) | 15.0 (IQR = 12.0) | 12.0 (IQR = 15.5) | |||
Wilcoxon test, level of significance P < 0.05.
GES: global exposure score; OES: occupational exposure score; NOES: non-occupational exposure; GES=OES+NOES.
Compared female and male patients’ exposure scores from DELCQ in SSc and RA
| Exposure scores . | SSc (n = 100) . | RA (n = 97) . | |||||
|---|---|---|---|---|---|---|---|
| Women (n = 74) . | Men (n = 26) . | P* . | Women (n = 77) . | Men (n = 20) . | P* . | ||
| GES | Mean | 20.7 (s.d. = 14.5) | 46.5 (s.d. = 19.7) | 1.27*10-7 | 25.3 (s.d. = 15.0) | 40.1(s.d. = 20.7) | 0.002 |
| Median | 17.5 (IQR = 20.0) | 47.0 (IQR = 23.0) | 25.0 (IQR = 21.0) | 42.5 (IQR = 28.0) | |||
| OES | Mean | 8.0 (s.d. = 8.5) | 30.0 (s.d. = 18.3) | 3.37*10-9 | 9.6 (s.d. = 9.0) | 26.5 (s.d. = 16.2) | 4.11*10-6 |
| Median | 6.0 (IQR = 13.0) | 26.0 (IQR = 22.0) | 7.0 (IQR = 11.0) | 23.5 (IQR = 16.5) | |||
| NOES | Mean | 12.7 (s.d. = 9.7) | 16.4 (s.d. = 9.5) | 0.08 | 15.7 (s.d. = 8.9) | 13.5 (s.d. = 9.9) | 0.31 |
| Median | 11 (IQR = 14.0) | 15.5 (IQR = 17.0) | 15.0 (IQR = 12.0) | 12.0 (IQR = 15.5) | |||
| Exposure scores . | SSc (n = 100) . | RA (n = 97) . | |||||
|---|---|---|---|---|---|---|---|
| Women (n = 74) . | Men (n = 26) . | P* . | Women (n = 77) . | Men (n = 20) . | P* . | ||
| GES | Mean | 20.7 (s.d. = 14.5) | 46.5 (s.d. = 19.7) | 1.27*10-7 | 25.3 (s.d. = 15.0) | 40.1(s.d. = 20.7) | 0.002 |
| Median | 17.5 (IQR = 20.0) | 47.0 (IQR = 23.0) | 25.0 (IQR = 21.0) | 42.5 (IQR = 28.0) | |||
| OES | Mean | 8.0 (s.d. = 8.5) | 30.0 (s.d. = 18.3) | 3.37*10-9 | 9.6 (s.d. = 9.0) | 26.5 (s.d. = 16.2) | 4.11*10-6 |
| Median | 6.0 (IQR = 13.0) | 26.0 (IQR = 22.0) | 7.0 (IQR = 11.0) | 23.5 (IQR = 16.5) | |||
| NOES | Mean | 12.7 (s.d. = 9.7) | 16.4 (s.d. = 9.5) | 0.08 | 15.7 (s.d. = 8.9) | 13.5 (s.d. = 9.9) | 0.31 |
| Median | 11 (IQR = 14.0) | 15.5 (IQR = 17.0) | 15.0 (IQR = 12.0) | 12.0 (IQR = 15.5) | |||
Wilcoxon test, level of significance P < 0.05.
GES: global exposure score; OES: occupational exposure score; NOES: non-occupational exposure; GES=OES+NOES.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
